Scarica l'app Stockscreener
0.3634
4.07%
-0.0154
Precedente Chiudi:
$0.3788
Aprire:
$0.369501
Volume 24 ore:
31,187
Relative Volume:
0.09
Capitalizzazione di mercato:
$6.53M
Reddito:
$10.34M
Utile/perdita netta:
$-3.09M
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
$-736.20K
1 W Prestazione:
-4.37%
1M Prestazione:
-13.82%
6M Prestazione:
-39.83%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$0.36
$0.3753
Intervallo di 1 settimana:
$0.355
$0.38
Portata 52W:
$0.34
$3.39
Bionexus Gene Lab Corp Stock (BGLC) Company Profile
Nome
Bionexus Gene Lab Corp
Settore
Industria
Telefono
1-307-241-6898
Indirizzo
10-2 TOWER B, VERTICAL BUSINESS SUITE,, KUALA LUMPUR
Bionexus Gene Lab Corp Borsa (BGLC) Ultime notizie
BioNexus Gene Lab announces board resignations By Investing.com - Investing.com Australia
BioNexus Gene Lab announces board resignations - Investing.com India
BioNexus Gene Lab faces vote impact from alleged proxy issues By Investing.com - Investing.com Australia
BioNexus Gene Lab faces vote impact from alleged proxy issues - Investing.com India
bionexus gene lab corp Earnings dates - RTTNews
BioNexus Gene Lab Corp. (NASDAQ:BGLC) Short Interest Update - Defense World
BioNexus Gene Lab Corporation announces entry into Biogas - GlobeNewswire
BioNexus Gene Lab Corporation announces entry into Biogas Sector via Teaming Agreement with Protech Builders Sdn. Bhd. - StockTitan
BioNexus Gene Lab Corp (BGLC) Stock: A Year of Market Fluctuations - The InvestChronicle
There is no way BioNexus Gene Lab Corp (BGLC) can keep these numbers up - SETE News
In the Green: BioNexus Gene Lab Corp (BGLC) Closes at 0.39, Up/Down 8.36 from Previous Day - The Dwinnex
BioNexus partners with Vitarray for gene detection - Investing.com
BioNexus Gene Lab Corp. Signs Strategic Outsourcing Agreement with VITARRAY Global Pte. Ltd. - Marketscreener.com
BioNexus Gene Lab Corp (BGLC) requires closer examination - US Post News
Bionexus Gene Lab in MOU with Shenzhen Rongguang Group for cancer screening - TipRanks
BioNexus Gene Lab Corp. Signs Strategic Partnership MOU with Shenzhen Rongguang Group to Advance Cancer Screening, Precision Medicine, and Preventative Healthcare Solutions - GlobeNewswire
Closing Figures: BioNexus Gene Lab Corp (BGLC)’s Positive Finish at 0.36, Up 2.48 - The Dwinnex
BioNexus Gene Lab Corp (BGLC) Stock: 52-Week Performance Insights and Trading Volume - The InvestChronicle
BioNexus subsidiary invests in color paste production By Investing.com - Investing.com India
Bionexus Gene Lab’s Chemrex invests RM 2M to begin color paste production - TipRanks
BioNexus Gene Lab Corp Announces New Business Developments for Subsidiary Chemrex with Investment in High-Quality Color Paste Production - StockTitan
BioNexus Gene Lab Corp revises stockholder quorum requirement - Investing.com India
How did BioNexus Gene Lab Corp (BGLC) fare last session? - US Post News
An analyst sees good growth prospects for BioNexus Gene Lab Corp (BGLC) - SETE News
BioNexus Receives Government Backing for Healthcare Tech - TipRanks
BioNexus and MyCIF invest in Malaysian healthcare tech By Investing.com - Investing.com Australia
BioNexus Gene Lab Corp. Announces Successful Securities Commission of Malaysia (MyCIF) Co-Investment in Ascension Innovation Sdn Bhd - Yahoo Finance UK
BioNexus Gene Lab Corp (BGLC)’s Market Momentum: Closing Strong at 0.44, Up 4.05 - The Dwinnex
BioNexus Gene Lab’s Strategic Investment in AI Healthcare - TipRanks
BioNexus Gene Lab Corp. Completes Strategic RM 1 Million Investment in Ascension Innovation Sdn Bhd - Marketscreener.com
Ascension Innovation raises RM1.7m funding - The Malaysian Reserve
BioNexus Gene Lab Second Quarter 2024 Earnings: US$0.005 loss per share (vs US$0.018 loss in 2Q 2023) - Yahoo Finance
Ascension Innovation Becomes First ECF Issuer To Secure MyCIF Environmental & Social Impact Fund - BusinessToday
Reviewing Exagen (NASDAQ:XGN) and BioNexus Gene Lab (NASDAQ:BGLC) - Defense World
Short Interest in BioNexus Gene Lab Corp. (NASDAQ:BGLC) Declines By 48.8% - Defense World
Critical Review: BioNexus Gene Lab (NASDAQ:BGLC) & RadNet (NASDAQ:RDNT) - Defense World
BGLC’s Market Quandary: Decoding the Ups and Downs of 2023 - The InvestChronicle
BioNexus Gene Lab Corp. (NASDAQ:BGLC) Sees Significant Increase in Short Interest - Defense World
BioNexus Gene Lab Corp. (NASDAQ:BGLC) Sees Significant Growth in Short Interest - American Banking and Market News
BioNexus Gene Lab Corp. Announces Closing of $5.75 Million Public Offering and Full Exercise of Over-Allotment ... - Quantisnow
Financial Snapshot: Analyzing BioNexus Gene Lab Corp (BGLC)'s Key Ratio Metrics – DWinneX - The Dwinnex
Is BioNexus Gene Lab Corp (BGLC) a opportunity to investors? – US Post News - US Post News
BioNexus Gene Lab Corp. (NASDAQ:BGLC) Short Interest Down 44.8% in May - Defense World
Psychemedics (NASDAQ:PMD) and BioNexus Gene Lab (NASDAQ:BGLC) Head to Head Analysis - Defense World
There is no way BioNexus Gene Lab Corp (BGLC) can keep these numbers up – Sete News - SETE News
Market Recap: BioNexus Gene Lab Corp (BGLC)'s Positive Momentum, Closing at 0.50 – DWinneX - The Dwinnex
Lotto 6/49$50 million up for grabs in the next draw! - Yahoo Canada Finance
Why Wang & Lee Group Shares Are Trading Higher By 38%; Here Are 20 Stocks Moving Premarket - Benzinga
BioNexus Gene Lab Expands Reach with Strategic InvestmentTipRanks.com - TipRanks
BioNexus Gene Lab Corp. Agrees to Invest RM 1.2 million in Ascension Innovation (AISB) to Advance Digital Health Innovation through AI adoption in Healthcare - Yahoo Finance
Bionexus Gene Lab Corp Azioni (BGLC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.54%
0.17%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):